Cargando…
Evaluating an automated machine learning model that predicts visual acuity outcomes in patients with neovascular age-related macular degeneration
PURPOSE: Neovascular age-related macular degeneration (nAMD) is a major global cause of blindness. Whilst anti-vascular endothelial growth factor (anti-VEGF) treatment is effective, response varies considerably between individuals. Thus, patients face substantial uncertainty regarding their future a...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9325856/ https://www.ncbi.nlm.nih.gov/pubmed/35122132 http://dx.doi.org/10.1007/s00417-021-05544-y |
_version_ | 1784757150615076864 |
---|---|
author | Abbas, Abdallah O’Byrne, Ciara Fu, Dun Jack Moraes, Gabriella Balaskas, Konstantinos Struyven, Robbert Beqiri, Sara Wagner, Siegfried K. Korot, Edward Keane, Pearse A. |
author_facet | Abbas, Abdallah O’Byrne, Ciara Fu, Dun Jack Moraes, Gabriella Balaskas, Konstantinos Struyven, Robbert Beqiri, Sara Wagner, Siegfried K. Korot, Edward Keane, Pearse A. |
author_sort | Abbas, Abdallah |
collection | PubMed |
description | PURPOSE: Neovascular age-related macular degeneration (nAMD) is a major global cause of blindness. Whilst anti-vascular endothelial growth factor (anti-VEGF) treatment is effective, response varies considerably between individuals. Thus, patients face substantial uncertainty regarding their future ability to perform daily tasks. In this study, we evaluate the performance of an automated machine learning (AutoML) model which predicts visual acuity (VA) outcomes in patients receiving treatment for nAMD, in comparison to a manually coded model built using the same dataset. Furthermore, we evaluate model performance across ethnic groups and analyse how the models reach their predictions. METHODS: Binary classification models were trained to predict whether patients’ VA would be ‘Above’ or ‘Below’ a score of 70 one year after initiating treatment, measured using the Early Treatment Diabetic Retinopathy Study (ETDRS) chart. The AutoML model was built using the Google Cloud Platform, whilst the bespoke model was trained using an XGBoost framework. Models were compared and analysed using the What-if Tool (WIT), a novel model-agnostic interpretability tool. RESULTS: Our study included 1631 eyes from patients attending Moorfields Eye Hospital. The AutoML model (area under the curve [AUC], 0.849) achieved a highly similar performance to the XGBoost model (AUC, 0.847). Using the WIT, we found that the models over-predicted negative outcomes in Asian patients and performed worse in those with an ethnic category of Other. Baseline VA, age and ethnicity were the most important determinants of model predictions. Partial dependence plot analysis revealed a sigmoidal relationship between baseline VA and the probability of an outcome of ‘Above’. CONCLUSION: We have described and validated an AutoML-WIT pipeline which enables clinicians with minimal coding skills to match the performance of a state-of-the-art algorithm and obtain explainable predictions. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s00417-021-05544-y. |
format | Online Article Text |
id | pubmed-9325856 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Springer Berlin Heidelberg |
record_format | MEDLINE/PubMed |
spelling | pubmed-93258562022-07-28 Evaluating an automated machine learning model that predicts visual acuity outcomes in patients with neovascular age-related macular degeneration Abbas, Abdallah O’Byrne, Ciara Fu, Dun Jack Moraes, Gabriella Balaskas, Konstantinos Struyven, Robbert Beqiri, Sara Wagner, Siegfried K. Korot, Edward Keane, Pearse A. Graefes Arch Clin Exp Ophthalmol Retinal Disorders PURPOSE: Neovascular age-related macular degeneration (nAMD) is a major global cause of blindness. Whilst anti-vascular endothelial growth factor (anti-VEGF) treatment is effective, response varies considerably between individuals. Thus, patients face substantial uncertainty regarding their future ability to perform daily tasks. In this study, we evaluate the performance of an automated machine learning (AutoML) model which predicts visual acuity (VA) outcomes in patients receiving treatment for nAMD, in comparison to a manually coded model built using the same dataset. Furthermore, we evaluate model performance across ethnic groups and analyse how the models reach their predictions. METHODS: Binary classification models were trained to predict whether patients’ VA would be ‘Above’ or ‘Below’ a score of 70 one year after initiating treatment, measured using the Early Treatment Diabetic Retinopathy Study (ETDRS) chart. The AutoML model was built using the Google Cloud Platform, whilst the bespoke model was trained using an XGBoost framework. Models were compared and analysed using the What-if Tool (WIT), a novel model-agnostic interpretability tool. RESULTS: Our study included 1631 eyes from patients attending Moorfields Eye Hospital. The AutoML model (area under the curve [AUC], 0.849) achieved a highly similar performance to the XGBoost model (AUC, 0.847). Using the WIT, we found that the models over-predicted negative outcomes in Asian patients and performed worse in those with an ethnic category of Other. Baseline VA, age and ethnicity were the most important determinants of model predictions. Partial dependence plot analysis revealed a sigmoidal relationship between baseline VA and the probability of an outcome of ‘Above’. CONCLUSION: We have described and validated an AutoML-WIT pipeline which enables clinicians with minimal coding skills to match the performance of a state-of-the-art algorithm and obtain explainable predictions. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s00417-021-05544-y. Springer Berlin Heidelberg 2022-02-05 2022 /pmc/articles/PMC9325856/ /pubmed/35122132 http://dx.doi.org/10.1007/s00417-021-05544-y Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
spellingShingle | Retinal Disorders Abbas, Abdallah O’Byrne, Ciara Fu, Dun Jack Moraes, Gabriella Balaskas, Konstantinos Struyven, Robbert Beqiri, Sara Wagner, Siegfried K. Korot, Edward Keane, Pearse A. Evaluating an automated machine learning model that predicts visual acuity outcomes in patients with neovascular age-related macular degeneration |
title | Evaluating an automated machine learning model that predicts visual acuity outcomes in patients with neovascular age-related macular degeneration |
title_full | Evaluating an automated machine learning model that predicts visual acuity outcomes in patients with neovascular age-related macular degeneration |
title_fullStr | Evaluating an automated machine learning model that predicts visual acuity outcomes in patients with neovascular age-related macular degeneration |
title_full_unstemmed | Evaluating an automated machine learning model that predicts visual acuity outcomes in patients with neovascular age-related macular degeneration |
title_short | Evaluating an automated machine learning model that predicts visual acuity outcomes in patients with neovascular age-related macular degeneration |
title_sort | evaluating an automated machine learning model that predicts visual acuity outcomes in patients with neovascular age-related macular degeneration |
topic | Retinal Disorders |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9325856/ https://www.ncbi.nlm.nih.gov/pubmed/35122132 http://dx.doi.org/10.1007/s00417-021-05544-y |
work_keys_str_mv | AT abbasabdallah evaluatinganautomatedmachinelearningmodelthatpredictsvisualacuityoutcomesinpatientswithneovascularagerelatedmaculardegeneration AT obyrneciara evaluatinganautomatedmachinelearningmodelthatpredictsvisualacuityoutcomesinpatientswithneovascularagerelatedmaculardegeneration AT fudunjack evaluatinganautomatedmachinelearningmodelthatpredictsvisualacuityoutcomesinpatientswithneovascularagerelatedmaculardegeneration AT moraesgabriella evaluatinganautomatedmachinelearningmodelthatpredictsvisualacuityoutcomesinpatientswithneovascularagerelatedmaculardegeneration AT balaskaskonstantinos evaluatinganautomatedmachinelearningmodelthatpredictsvisualacuityoutcomesinpatientswithneovascularagerelatedmaculardegeneration AT struyvenrobbert evaluatinganautomatedmachinelearningmodelthatpredictsvisualacuityoutcomesinpatientswithneovascularagerelatedmaculardegeneration AT beqirisara evaluatinganautomatedmachinelearningmodelthatpredictsvisualacuityoutcomesinpatientswithneovascularagerelatedmaculardegeneration AT wagnersiegfriedk evaluatinganautomatedmachinelearningmodelthatpredictsvisualacuityoutcomesinpatientswithneovascularagerelatedmaculardegeneration AT korotedward evaluatinganautomatedmachinelearningmodelthatpredictsvisualacuityoutcomesinpatientswithneovascularagerelatedmaculardegeneration AT keanepearsea evaluatinganautomatedmachinelearningmodelthatpredictsvisualacuityoutcomesinpatientswithneovascularagerelatedmaculardegeneration |